LOGAN FORD: Open Payments
NPI 1972211381 · GEORGETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 39 payments from 12 companies in 2025. Trend: 2023 $1,381 · 2024 $1,660 · 2025 $847
Food & beverage: $791Education: $56
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $214 |
| GENZYME CORPORATION | 7 | $153 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $89 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| SANOFI-AVENTIS U.S. LLC | 1 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Genentech USA, Inc. | 2 | $42 |
| Medtronic, Inc. | 1 | $28 |
| Optinose US, Inc. | 1 | $21 |
Products named: DUPIXENT, FASENRA, NEFFY, Xolair, TRELEGY ELLIPTA, AIRSUPRA, BREZTRI, ABRE.
Industry payments across DE — which companies pay providers there.
